Efficacy and safety of tezepelumab versus placebo in reducing oral corticosteroid use in adults with severe, oral corticosteroid-dependent asthma
Jun 03, 2026

These findings show that patients receiving tezepelumab can reduce maintenance oral corticosteroid use while maintaining asthma control and without compromising efficacy.


Lung Sask in collaboration with RESPTREC® offers the Professional Education Portal as a method for respiratory educators and health care providers to enhance their professional learning with continuing education opportunities.

Over 6000+ more articles available in the Professional Education Portal.

Read articles and watch video presentations on the most recent research, position papers and guidelines. Track your CE time with the provided logbook.

Access this free resource